Congratulations to BME professor & Integra LifeSciences Term Professor, Dr. Cherie Stabler, who was elected to serve as President-Elect for the Americas Chapter of TERMIS (Tissue Engineering and Regenerative Medicine International Society).
Dr. Stabler’s research centers on engineering translational biomaterial platforms for cell-based therapies, particularly Type 1 diabetes. Specifically, her research seeks to develop bioactive materials capable of: protecting cells from immunological attack; providing 3-D support of the transplanted cells; presenting cues for guiding positive host cell remodeling; and releasing therapeutic agents. Through the fabrication of novel biomaterials capable of actively interfacing with the host, she seeks to optimize the graft environment to favor the long-term survival and function of the implanted cells.
TERMIS brings together the international community of persons engaged or interested in the field of tissue engineering and regenerative medicine and promotes education and research within the field of tissue engineering and regenerative medicine through regular meetings, publications, and other forms of communication. The Society also serves as an international forum to promote the informed discussion of challenges and therapeutic benefits of the application of tissue engineering and regenerative medicine technologies.